BDBM471884 1-cyclopropyl-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)-2-((((1s,4S)-4- (trifluoromethyl)cyclohexyl)oxy)methyl)-1H- benzo[d]imidazole-5-carboxamide::US10829448, Compound BE-71.1

SMILES CCS(=O)(=O)c1ccc(cc1)[C@H](CO)NC(=O)c1ccc2n(C3CC3)c(CO[C@H]3CC[C@@H](CC3)C(F)(F)F)nc2c1

InChI Key InChIKey=OPVMIQJDAOQVFU-XTJBDQBJSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 471884   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Vitae Pharmaceuticals

US Patent
LigandPNGBDBM471884(1-cyclopropyl-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2...)
Affinity DataKi: <100nMAssay Description:Compounds described herein were tested for ability to bind to RORγ in a cell-free competition assay with commercially available radio-ligand (RL...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent